Madrigal Pharmaceuticals (MDGL) Treasury Shares (2011 - 2026)
Madrigal Pharmaceuticals (MDGL) reported Treasury Shares of $960898.0 for Q1 2026, up 38.26% year-over-year from $694995.0 in Q1 2025, and up 20.35% quarter-over-quarter from $798422.0 in Q4 2025.
Madrigal Pharmaceuticals (MDGL) Treasury Shares (2011 - 2026) Analysis & Trends
Madrigal Pharmaceuticals (MDGL) has 13 years of Treasury Shares data on file, last reported at $960898.0 in Q1 2026.
- Treasury Shares for Q1 2026 came in at $960898.0, up 38.26% year-over-year; the trailing twelve-month figure through Mar 2026 was $960898.0 (up 38.26% YoY), and the FY2025 annual result was $798422.0, up 239.0% from the prior year.
- Treasury Shares grew to $960898.0 in Q1 2026 per MDGL's latest filing, from $798422.0 in the prior quarter.
- Over five years, Treasury Shares peaked at $960898.0 in Q1 2026 and troughed at $199125.0 in Q1 2023.
- A 4-year average of $494654.3 and a median of $502867.0 in 2024 frame the typical range for Treasury Shares.
- On a YoY basis, Treasury Shares climbed as much as 239.0% in 2025 and fell as far as 39.3% in 2025.
- A 4-year view of Treasury Shares shows it stood at $376117.0 in 2023, then sank by 37.38% to $235520.0 in 2024, then jumped by 239.0% to $798422.0 in 2025, then advanced by 20.35% to $960898.0 in 2026.
- Business Quant data shows MDGL's Treasury Shares at $960898.0 in Q1 2026, $798422.0 in Q4 2025, and $779923.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 1.48 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 700,000.00 |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Madrigal Pharmaceuticals | 14.67 Bn | 14.44 Bn | - | 960,898.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 960,898.00 |
| Mar 31, 2026 | 960,898.00 |
| Dec 31, 2025 | 798,422.00 |
| Dec 31, 2025 | 798,422.00 |
| Sep 30, 2025 | 779,923.00 |
| Sep 30, 2025 | 779,923.00 |
| Jun 30, 2025 | 308,954.00 |
| Jun 30, 2025 | 308,954.00 |
| Mar 31, 2025 | 694,995.00 |
| Mar 31, 2025 | 694,995.00 |
| Dec 31, 2024 | 235,520.00 |
| Dec 31, 2024 | 235,520.00 |
| Sep 30, 2024 | 502,867.00 |
| Sep 30, 2024 | 502,867.00 |
| Jun 30, 2024 | 508,947.00 |
| Jun 30, 2024 | 508,947.00 |
| Mar 31, 2024 | 530,671.00 |
| Mar 31, 2024 | 530,671.00 |
| Dec 31, 2023 | 376,117.00 |
| Dec 31, 2023 | 376,117.00 |